ReviewBiological psychiatry global open science2026
GLP-1 Receptor Agonist and GIP/GLP-1 Receptor Dual Agonist Therapeutics at the Intersection of Alcohol Use Disorder, Obesity, and Cardiometabolic Dysfunction.
Joshua Reitz et al.PubMed ↗Full text ↗Publisher ↗
No numbers read from the abstract.